An innovative automated eye drop dispenser aid for the self-administration of eye drops to increase independence in the ageing population, improve eye health outcomes and reduce NHS/social care costs

一种创新的自动滴眼液分配器,有助于自行滴眼药水,以提高老年人口的独立性,改善眼部健康状况并降低 NHS/社会护理成本

基本信息

  • 批准号:
    10043150
  • 负责人:
  • 金额:
    $ 6.33万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Grant for R&D
  • 财政年份:
    2022
  • 资助国家:
    英国
  • 起止时间:
    2022 至 无数据
  • 项目状态:
    已结题

项目摘要

Eye medication is unique as it is usually self-administered as eye drops. Eye drop application, however, presents a major challenge, particularly for older patients. Studies show that over 50% of patients actually miss their eye and 20% of people cannot apply sufficient force to squeeze the bottle, requiring someone else to apply the drops for them. Due to the variety of bottle designs and treatment regimes, so far no solution has been found other than district nurse input, or occasionally hospital admission. For those who can afford it, private carers are occasionally employed.Without social care input, many of these patients would miss vital medication, which could result in progressive sight loss and the associated health and economic burden. Sight loss has a severe negative impact on a person's life, affecting their work, social life, physical and mental health.Improper drop application presents a huge cost to the NHS and social care budgets. When this is combined with associated sub-optimal clinical care, including increased hospital visits and escalation of treatment, as well as visual impairment, the cost is far higher.The long-term demographic trend of an ageing UK population means that over the next 20 years, a 50% increase in cataract surgery and 44% rise in glaucoma cases are forecasted and many more patients will be requiring district nurse input. To meet this challenge, we have developed a novel device to aid the self-administration of eye drops.We have designed the world's first fully automated eye drop dispenser. This handheld device will enable even the frailest of patients to safely and accurately self-administer their own eye drops. Our device will be the first of its kind and has been designed to overcome the major challenges associated with the self-administration of eye drops. Research has shown barriers to self-administration to be both physical and cognitive and our device is the first to address every issue that these patients have.This device will reduce the risk of sight loss, allowing elderly patients to continue to live fulfilled independent lives, contribute to society, and take control of their own eye health without relying on others. Making drop application more accessible to all helps to reduce inequalities in eye health between those that have the ability to apply their own medication or pay for private carers, and those that cannot.
眼科药物是独特的,因为它通常是作为眼药水自行施用。然而,滴眼液的应用是一个重大挑战,特别是对老年患者。研究表明,超过50%的患者实际上漏掉了眼睛,20%的人无法用足够的力量挤瓶子,需要别人为他们滴眼药水。由于瓶子设计和治疗方案的多样性,到目前为止,除了地区护士投入或偶尔住院外,还没有找到其他解决方案。对于那些负担得起的人,偶尔会雇佣私人护工。如果没有社会关怀的投入,这些患者中的许多人将错过重要的药物治疗,这可能导致进行性视力丧失,并带来相关的健康和经济负担。失明对一个人的生活有严重的负面影响,影响到他们的工作、社会生活和身心健康。不适当的drop应用给NHS和社会保健预算带来了巨大的成本。当这与相关的次优临床护理相结合时,包括医院就诊次数增加和治疗升级,以及视力障碍,成本要高得多。英国人口老龄化的长期人口趋势意味着,在未来20年里,预计白内障手术将增加50%,青光眼病例将增加44%,更多的患者将需要地区护士的帮助。为了应对这一挑战,我们开发了一种新颖的设备来帮助人们自行滴眼液。我们设计了世界上第一台全自动滴眼液机。这种手持设备将使即使是最虚弱的病人也能安全、准确地自行使用眼药水。我们的设备将是同类产品中的第一个,旨在克服与自我滴眼液相关的主要挑战。研究表明,自我管理的障碍既有身体上的,也有认知上的,我们的设备是第一个解决这些患者所有问题的设备。该装置将降低视力丧失的风险,使老年患者能够继续过着充实的独立生活,为社会做出贡献,并在不依赖他人的情况下控制自己的眼睛健康。使所有人都更容易获得滴眼液,有助于减少有能力自行用药或支付私人护理费用的人与没有能力的人之间在眼保健方面的不平等。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Studentship

相似海外基金

A Connectomic Analysis of a Developing Brain Undergoing Neurogenesis
正在经历神经发生的发育中大脑的连接组学分析
  • 批准号:
    10719296
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
BRITE-Eye: An integrated discovery engine for CNS therapeutic targets driven by high throughput genetic screens, functional readouts in human neurons, and machine learning
BRITE-Eye:由高通量遗传筛选、人类神经元功能读数和机器学习驱动的中枢神经系统治疗靶点的集成发现引擎
  • 批准号:
    10699137
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
Computational phenotyping of face expression in early psychosis
早期精神病面部表情的计算表型
  • 批准号:
    10608718
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
Radiomics Features of Quantitative Interstitial Abnormalities and Early Pulmonary Fibrosis
定量间质异常和早期肺纤维化的放射组学特征
  • 批准号:
    10603453
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
MMP-9 based immune-driven mechanisms of neovascular AMD
基于MMP-9的新生血管性AMD的免疫驱动机制
  • 批准号:
    10719958
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
Automated system to improve compliance to diabetic retinopathy screening
自动化系统可提高糖尿病视网膜病变筛查的依从性
  • 批准号:
    10697609
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring
整合智能手机沙眼摄影、智能手机视力评估和移动自动验光,加强社区公共卫生监测
  • 批准号:
    10908756
  • 财政年份:
    2023
  • 资助金额:
    $ 6.33万
  • 项目类别:
Automated Digital Diabetic Retinopathy Eye Screening System (ADDRESS)
自动数字糖尿病视网膜病变眼部筛查系统(ADDRESS)
  • 批准号:
    10034967
  • 财政年份:
    2022
  • 资助金额:
    $ 6.33万
  • 项目类别:
    Collaborative R&D
Mechanistic analysis of Toxoplasma gondii sexual development in tissue culture and mouse models
组织培养和小鼠模型中弓形虫性发育的机制分析
  • 批准号:
    10533513
  • 财政年份:
    2022
  • 资助金额:
    $ 6.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了